US$ 22.00
daily oral glp-1 receptor agonist orforglipron for adults with obesity VisualAbstract: Original Article: Daily Oral GLP-1
Description
GCSI Scoring System for Patient-Reported Outcomes The GCSI is a patient-based symptom instrument in which the score is a sum of three subscale scores (each ranging from 1 to 3) for the three main symptom complexes: 1

Manne-Goehler J, Franco J

GLP-1 Receptor Stimulation Preserves Primary Cortical and Dopaminergic Neurons in Cellular and Rodent Models of Stroke and Parkinsonism
However, rodent studies suggest a link to medullary thyroid cancer, leading to contraindications for individuals with a personal or family history of MEN2A or medullary thyroid cancer [13]

Fatty Acid Modification : Leveraging interactions between fatty acids and albumin for metabolic stability and circulation, and using the self-association and ionic properties of fatty acids to extend the drug's half-life
Cold exposure and exercise timing Brief cold exposure (cold showers, cold water immersion) has been shown to activate brown adipose tissue and increase GLP-1 secretion in several human studies
